229 related articles for article (PubMed ID: 17697913)
1. The cycle of migraine: patients' quality of life during and between migraine attacks.
Freitag FG
Clin Ther; 2007 May; 29(5):939-949. PubMed ID: 17697913
[TBL] [Abstract][Full Text] [Related]
2. The migraine cycle: patient burden of migraine during and between migraine attacks.
Brandes JL
Headache; 2008 Mar; 48(3):430-41. PubMed ID: 18179565
[TBL] [Abstract][Full Text] [Related]
3. The effect of migraine prophylaxis on migraine-related resource use and productivity.
Láinez MJ
CNS Drugs; 2009 Sep; 23(9):727-38. PubMed ID: 19689164
[TBL] [Abstract][Full Text] [Related]
4. Topiramate for migraine prevention.
Wenzel RG; Schwarz K; Padiyara RS
Pharmacotherapy; 2006 Mar; 26(3):375-87. PubMed ID: 16503717
[TBL] [Abstract][Full Text] [Related]
5. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment.
Brown JS; Papadopoulos G; Neumann PJ; Friedman M; Miller JD; Menzin J
Headache; 2005 Sep; 45(8):1012-22. PubMed ID: 16109115
[TBL] [Abstract][Full Text] [Related]
7. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
8. Neuromodulators for migraine prevention.
Kaniecki R
Headache; 2008 Apr; 48(4):586-600. PubMed ID: 18205800
[TBL] [Abstract][Full Text] [Related]
9. Global trends in migraine care: results from the MAZE survey.
Brandes JL
CNS Drugs; 2002; 16 Suppl 1():13-8. PubMed ID: 12196035
[TBL] [Abstract][Full Text] [Related]
10. Topiramate in Migraine Prevention: A 2016 Perspective.
Silberstein SD
Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
[TBL] [Abstract][Full Text] [Related]
11. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.
Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D; Kilminster S
Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257
[TBL] [Abstract][Full Text] [Related]
12. Weight change associated with the use of migraine-preventive medications.
Taylor FR
Clin Ther; 2008 Jun; 30(6):1069-80. PubMed ID: 18640463
[TBL] [Abstract][Full Text] [Related]
13. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
[TBL] [Abstract][Full Text] [Related]
14. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
[TBL] [Abstract][Full Text] [Related]
15. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life.
Buse DC; Rupnow MF; Lipton RB
Mayo Clin Proc; 2009 May; 84(5):422-35. PubMed ID: 19411439
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
[TBL] [Abstract][Full Text] [Related]
17. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
Géraud G; Valette C
Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of pharmacotherapy for the prevention of migraine: a Markov model application.
Yu J; Smith KJ; Brixner DI
CNS Drugs; 2010 Aug; 24(8):695-712. PubMed ID: 20658800
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
